May 12, 2023... The U.S. Senate health committee passed a package of bills aimed at speeding generic drug competition and reining in pharmacy benefit managers.
April 27, 2023... Eli Lilly’s drug Mounjaro for type 2 diabetes helped people who are also overweight or obese lose up to 15.7% of their body weight in a new study.
April 27, 2023... Sen. Bill Cassidy’s new perch as the top Republican on the Senate health committee has attracted some campaign cash from pharma company execs.
April 18, 2023... GSK plans to purchase Bellus Health for $2 billion, adding a promising chronic cough drug to its pipeline.
April 10, 2023... PhRMA hasn’t put out a press release about a Texas judge suspending approval for mifepristone, even though the ruling could destabilize the FDA.
March 16, 2023... A U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years due to “serious breaches” involving promotion of a weight-loss drug.
March 13, 2023... Pfizer said it is acquiring Seagen, a maker of targeted cancer drugs, for $43 billion.
March 9, 2023... An experimental Eli Lilly drug failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease.
March 9, 2023... Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz ahead of his failed bid to represent Pennsylvania in the U.S. Senate.
Feb. 23, 2023... A court challenge to approval of mifepristone could set a sweeping precedent that might undermine the infrastructure for evaluating all drugs.
Feb. 15, 2023... Under Bourla’s leadership, Pfizer was the first to win FDA approval of an mRNA vaccine against Covid-19 in late 2020, along with its partner BioNTech, followed a year later by authorization for the oral Covid antiviral Paxlovid. Then, last August, Pfizer — simultaneously with Moderna — got the FDA’s nod last for a revamped vaccine…
Feb. 14, 2023... The biotech industry is in shake-out mode after the ranks of public drug developers swelled in recent years amid an IPO boom.
Jan. 31, 2023... Amgen's long-awaited pricing for its Humira biosimilar suggests the biggest winners may be health insurers and others in the supply chain, but not patients.
Jan. 30, 2023... Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the National Health Service.
Jan. 30, 2023... Pfizer was scolded by a U.K. pharmaceutical trade group after its CEO made misleading statements about the need to vaccinate young children against Covid-19.
Jan. 27, 2023... A U.K. pharmaceutical industry trade group ruled on a complaint that Pfizer CEO Albert Bourla's remarks to the BBC were “extremely promotional in nature.”
Jan. 26, 2023... An unexpected alliance is lobbying for Medicare to pay for new obesity drugs.
Jan. 17, 2023... Pfizer's effort comes amid harsh criticism of the pharmaceutical industry for failing to do more to widen access to its products.
Jan. 11, 2023... Pfizer 's CEO said the company is not in talks with China to license a generic version of its Covid-19 pill, Paxlovid, for use there.
Jan. 9, 2023... "This is the wrong move for public health and the wrong move for fighting the pandemic," one critic said.
Dec. 14, 2022... Two U.S. lawmakers urged the Pfizer CEO to “back off” from plans to charge Americans up to $130 for the company’s Covid-19 vaccine.
Dec. 13, 2022... In a letter to the Pfizer CEO, U.S. Sen. Elizabeth Warren (D-Mass) and Sen. Peter Welch (D-Vt) called the price hike "pure and deadly greed."
Nov. 28, 2022... A 65-year-old woman who was receiving lecanemab for early Alzheimer’s disease died from a massive brain hemorrhage that some researchers link to the drug.
Nov. 21, 2022... Provention Bio priced its new type 1 diabetes prevention therapy at $13,850 per vial — equivalent to almost $194,000 for its 14-day course — a higher level than predicted by analysts.
Nov. 18, 2022... Pfizer's CEO says the company's Covid vaccines will remain "free for all Americans" — an assertion that overlooked indirect costs that will be passed on to consumers.
Nov. 16, 2022... Vaccine researcher Kathrin Jansen said at the #STATSummit that a flu pandemic is inevitable: “The question is, does it come tomorrow or 50 years from now?”
Oct. 17, 2022... Vaccines that target cancer could be available before the end of the decade, said the husband and wife team behind one of the most successful Covid shots.
Oct. 17, 2022... In an unusual step, the European Public Prosecutor’s Office confirmed it has opened an investigation into the Covid-19 contracts the European Union made with Pfizer.
Sept. 30, 2022... The FDA approved a new medicine for ALS from Amylyx Pharmaceuticals, providing a desperately needed new treatment option.
